-
Rethinking Clinical Trials
Could changes spurred by safety concerns during the pandemic make clinical trials more accessible to patients?
by Charlotte Huff
-
More Options for Treating Melanoma
With targeted drugs, immunotherapies and treatment combinations now available, people with advanced melanoma have choices to make.
by Kendall K. Morgan
-
Exercise, Cancer and Aging
A study on aging shows that cancer survivors are at higher risk of losing strength and walking more slowly compared to those with no cancer history. Exercise is one way to combat this decline.
by Marcus A. Banks
-
Open Medical Records: Pros and Cons
Patients now have full access to their online medical records. What are the benefits and downsides?
by Jen Tota McGivney
-
Survivor Profile
Breaking Down BarriersCancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research.
by Bradley Jones
-
Survivor Profile
A Return to CarnivalWith a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents' native Trinidad to celebrate the Caribbean festival.
by Lindsey Konkel
-
Survivor Profile
A Voice at RiskRob Paulsen has voiced hundreds of animated characters, but as he prepared to return to a beloved role, cancer threatened his livelihood.
by Bradley Jones
-
Beating the Bully Inside
To gain control over fear of my breast cancer recurring, I called on lessons learned as a 5-year-old confronting the neighborhood bully.
by Joan Harris
-
Survivor Profile
An Unlikely PivotMedha Deoras-Sutliff's experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers.
by Lindsey Konkel
-
Survivor Profile
Sharing Her StrengthDiagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.
by Lindsey Konkel
Cancer Talk
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon